Emre M. Isin

2.3k total citations
38 papers, 1.8k citations indexed

About

Emre M. Isin is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Emre M. Isin has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 12 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Emre M. Isin's work include Pharmacogenetics and Drug Metabolism (25 papers), Drug Transport and Resistance Mechanisms (10 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Emre M. Isin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (25 papers), Drug Transport and Resistance Mechanisms (10 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Emre M. Isin collaborates with scholars based in United States, Sweden and United Kingdom. Emre M. Isin's co-authors include F. Peter Guengerich, Richard A. Thompson, Lars Weidolf, Charles S. Elmore, Göran N. Nilsson, Ulrik Jurva, Monday O. Ogese, J. Gerry Kenna, Jerome T. Mettetal and Dominic P. Williams and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Emre M. Isin

35 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emre M. Isin United States 18 897 647 328 273 272 38 1.8k
Manjunath S. Shet United States 21 664 0.7× 561 0.9× 265 0.8× 153 0.6× 131 0.5× 47 1.8k
Alfin D. N. Vaz United States 26 1.0k 1.1× 1.1k 1.7× 513 1.6× 637 2.3× 196 0.7× 59 2.7k
Ralph A. Stearns United States 27 1.3k 1.4× 715 1.1× 590 1.8× 150 0.5× 254 0.9× 68 2.5k
Donghak Kim South Korea 26 1.0k 1.1× 983 1.5× 385 1.2× 87 0.3× 256 0.9× 93 2.1k
Rakesh Paul India 8 1.1k 1.2× 1.1k 1.7× 511 1.6× 641 2.3× 217 0.8× 11 2.6k
Sekhar Boddupalli United States 11 931 1.0× 1.2k 1.8× 322 1.0× 201 0.7× 248 0.9× 13 2.0k
Patrik Rydberg Denmark 26 761 0.8× 897 1.4× 164 0.5× 434 1.6× 762 2.8× 43 1.9k
Martha V. Martin United States 25 1.9k 2.1× 1.1k 1.8× 780 2.4× 122 0.4× 232 0.9× 36 2.9k
Gilles Truan France 24 883 1.0× 1.1k 1.7× 262 0.8× 156 0.6× 209 0.8× 71 1.8k
Vaughn P. Miller United States 18 861 1.0× 541 0.8× 369 1.1× 103 0.4× 193 0.7× 25 1.6k

Countries citing papers authored by Emre M. Isin

Since Specialization
Citations

This map shows the geographic impact of Emre M. Isin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre M. Isin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre M. Isin more than expected).

Fields of papers citing papers by Emre M. Isin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre M. Isin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre M. Isin. The network helps show where Emre M. Isin may publish in the future.

Co-authorship network of co-authors of Emre M. Isin

This figure shows the co-authorship network connecting the top 25 collaborators of Emre M. Isin. A scholar is included among the top collaborators of Emre M. Isin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emre M. Isin. Emre M. Isin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isin, Emre M., et al.. (2024). How can MSI enhance our understanding of ASO distribution?. Drug Discovery Today. 30(1). 104275–104275.
2.
Walles, Markus, et al.. (2023). Meeting report of the 3rd European Biotransformation Workshop. Xenobiotica. 53(2). 123–127.
3.
Cox, Benoit, Patrick Barton, Reiner Class, et al.. (2022). Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation. SHILAP Revista de lepidopterología. 7. 100054–100054. 17 indexed citations
4.
Isin, Emre M., et al.. (2022). Multimodal molecular imaging in drug discovery and development. Drug Discovery Today. 27(8). 2086–2099. 36 indexed citations
5.
Walles, Markus, Axel Pähler, Emre M. Isin, & Lars Weidolf. (2022). Meeting report of the second European biotransformation workshop. Xenobiotica. 52(4). 426–431. 2 indexed citations
6.
Baek, Jong‐Min, Raine E. S. Thomson, Dominic J. B. Hunter, et al.. (2018). Engineering highly functional thermostable proteins using ancestral sequence reconstruction. Nature Catalysis. 1(11). 878–888. 138 indexed citations
7.
Gumulya, Yosephine, Raine E. S. Thomson, Dominic J. B. Hunter, et al.. (2018). Engineering Thermostable CYP2D Enzymes for Biocatalysis Using Combinatorial Libraries of Ancestors for Directed Evolution (CLADE). ChemCatChem. 11(2). 841–850. 18 indexed citations
8.
Iegre, Jessica, Martin A. Hayes, Richard A. Thompson, Lars Weidolf, & Emre M. Isin. (2016). Database Extraction of Metabolite Information of Drug Candidates: Analysis of 27 AstraZeneca Compounds with Human Absorption, Distribution, Metabolism, and Excretion Data. Drug Metabolism and Disposition. 44(5). 732–740. 9 indexed citations
9.
Thorsell, Annika, et al.. (2014). Covalent interactions of reactive rimonabant metabolites with biological targets. Toxicology Letters. 229. S249–S249.
10.
Thompson, Richard A., Emre M. Isin, Yan Li, et al.. (2012). In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs. Chemical Research in Toxicology. 25(8). 1616–1632. 153 indexed citations
11.
Bergström, Moa Andresen, et al.. (2011). Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist Rimonabant. Drug Metabolism and Disposition. 39(10). 1823–1832. 20 indexed citations
12.
Sohl, Christal D., et al.. (2008). Cooperativity in Oxidation Reactions Catalyzed by Cytochrome P450 1A2. Journal of Biological Chemistry. 283(11). 7293–7308. 48 indexed citations
13.
Suleman, N. Kamrudin, et al.. (2008). The tert-butoxyl radical mediated hydrogen atom transfer reactions of the Parkinsonian proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and selected tertiary amines. Bioorganic & Medicinal Chemistry. 16(18). 8557–8562. 13 indexed citations
14.
Isin, Emre M. & F. Peter Guengerich. (2008). Substrate binding to cytochromes P450. Analytical and Bioanalytical Chemistry. 392(6). 1019–1030. 103 indexed citations
15.
Kim, Dong‐Hyun, Keonhee Kim, Emre M. Isin, et al.. (2007). Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli. Protein Expression and Purification. 57(2). 188–200. 24 indexed citations
16.
Isin, Emre M. & F. Peter Guengerich. (2007). Multiple Sequential Steps Involved in the Binding of Inhibitors to Cytochrome P450 3A4. Journal of Biological Chemistry. 282(9). 6863–6874. 61 indexed citations
17.
Kim, Keonhee, Emre M. Isin, Chul‐Ho Yun, Dong‐Hyun Kim, & F. Peter Guengerich. (2006). Kinetic deuterium isotope effects for 7‐alkoxycoumarin O‐dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. FEBS Journal. 273(10). 2223–2231. 20 indexed citations
18.
Isin, Emre M. & F. Peter Guengerich. (2006). Complex reactions catalyzed by cytochrome P450 enzymes. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(3). 314–329. 340 indexed citations
19.
Isin, Emre M. & F. Peter Guengerich. (2006). Kinetics and Thermodynamics of Ligand Binding by Cytochrome P450 3A4. Journal of Biological Chemistry. 281(14). 9127–9136. 120 indexed citations
20.
Rimoldi, John M., et al.. (2005). A novel and selective monoamine oxidase B substrate. Bioorganic & Medicinal Chemistry. 13(20). 5808–5813. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manjunath S. Shet Breakdown of academic impact, for papers by Alfin D. N. Vaz Breakdown of academic impact, for papers by Ralph A. Stearns Breakdown of academic impact, for papers by Donghak Kim Breakdown of academic impact, for papers by Rakesh Paul Breakdown of academic impact, for papers by Sekhar Boddupalli Breakdown of academic impact, for papers by Patrik Rydberg Breakdown of academic impact, for papers by Martha V. Martin Breakdown of academic impact, for papers by Gilles Truan Breakdown of academic impact, for papers by Vaughn P. Miller
Rankless by CCL
2026